SCYNEXIS appoints director

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
In PersonPolitics & Policy: Market Impacts and Mid-Year Outlooks
- 06/24/2022
- Sofitel Washington DC Lafayette Square
- 8:30 AM – 12:00 PM ET
Webinar ReplaysExpand Your Perspective: Unlocking Insights Across the Supply Chain
- 05/11/2022
- On-Demand
- 1 Hour
Conference10th Annual Community Bankers Conference
- 05/16/2022
- Four Seasons Resort and Club, Dallas at Las Colinas
- Dallas, Texas
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

In This List

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

26 Jan, 2017 | 17:21

Author Ephraim Bie
Theme Healthcare & Pharmaceuticals

SCYNEXIS Inc. appointed Marion McCourt as a board member.

McCourt was most recently COO of biopharmaceutical company Medivation Inc. until it was acquired by Pfizer Inc. in September 2016. Her appointment expands SCYNEXIS' board to eight members.